Interní Med. 2012; 14(3): 104-106

Barrett´s esophagus, risk factors and management

MUDr.Radek Kroupa, Ph.D.
Interní gastroenterologická klinika, LF MU a Fakultní nemocnice Brno

Barrett´s esophagus (BE) is a premalignant lesion developed due to chronic gastroesophageal reflux. The squamous esophageal mucosa

is replaced by columnar epithelium. The squamocolumnar junction is displaced proximally and metaplastic epithelium should be

confirmed from biopsy samples. The risk of development of adenocarcinoma is 30–40 times higher in patiens with BE than in patients

without this condition. Incidence of cancer in patients with BE is approximatelly 0,2–0,5 % per year. Endoscopic surveillance program has

been established to diagnose early dysplasia and cancer. Antireflux therapy by acid suppressant drugs or surgery is an important part of

management. Guidelines for the surveillance and management have been published. High grade dysplasia and early adenocarcinoma

can be succesfully treated endoscopically. The surgical resection as an alternative option.

therapy.

Keywords: gastroesophageal reflux disease, Barrett´s esofagus, premalignant, proton pump inhibitors, fundoplication, endoscopic

Published: March 26, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kroupa R. Barrett´s esophagus, risk factors and management. Interní Med. 2012;14(3):104-106.
Download citation

References

  1. Dent J. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management. J Gastroenterol Hepatol. 2011; 26 (Suppl 1): 11-30. Go to original source... Go to PubMed...
  2. Lukáš K, et al. Refluxní choroba jícnu. Standardy České gastroenterologické společnosti - aktualizace 2009. Vnitř Lék 2009; 55(10): 967-975. Go to PubMed...
  3. Martínek J, Falt P, Gregar J, a kol. Radiofrekvenční ablace v gastrointestinálním traktu - aktuální stav ve světě a v ČR. Gastroent Hepatol 2011; 65(5): 279-285.
  4. Martínek J, Zavoral M. Barrettův jícen - jak sledovat a jak léčit. Postgraduální medicína 2009; 11(6): 674-682.
  5. Rejchrt S, Repák R, Bureš J. Endoskopická diagnostika a léčba časného adenokarcinomu jícnu. Endoskopie 2009; 18(4): 144-149.
  6. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140(3): e18-52. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.